Oshawa, Canada

Eduardo Gustavo Cammisa


Average Co-Inventor Count = 3.4

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Eduardo Gustavo Cammisa

Introduction

Eduardo Gustavo Cammisa is a notable inventor based in Oshawa, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative forms of Lapatinib. With a total of 2 patents to his name, Cammisa's work has the potential to impact the treatment of various medical conditions.

Latest Patents

Cammisa's latest patents include "Polymorphic forms of Lapatinib ditosylate and processes for their preparation." This patent introduces a crystalline form of Lapatinib, referred to as APO-I, along with methods for its preparation. Additionally, it presents a crystalline solvate form of Lapatinib, termed APO-II, and outlines the processes for making APO-II. Another significant patent is "Process for the preparation of lapatinib and its ditosylate salt," which details methods for preparing Lapatinib and its pharmaceutically acceptable salts through reductive amination and catalytic hydrogenation.

Career Highlights

Cammisa is currently associated with Apotex Pharmachem Inc., a leading company in the pharmaceutical industry. His work at Apotex has allowed him to focus on innovative drug formulations and processes that enhance the efficacy of treatments.

Collaborations

Throughout his career, Cammisa has collaborated with esteemed colleagues such as Carlos Zetina-Rocha and Gamini Weeratunga. These collaborations have fostered a productive environment for innovation and development in pharmaceutical research.

Conclusion

Eduardo Gustavo Cammisa's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…